BioElectronics’ ActiPatch® Therapy Alleviates Heel Pain

Heel Pain is the leading podiatric medical complaint FREDERICK, MD, USA, October 23, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the completion of a randomized, placebo controlled crossover trial on plantar fasciitis (heel pain) using ActiPatch®. ActiPatch uses pulsed shortwave field therapy to reduce pain, inflammation … Continue Reading

BioElectronics Signs Distributor for Poland

Med&Care will give BIEL Entry into the $2 billion Polish Medical Equipment Market FREDERICK, MD, USA, August 14, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it has signed an exclusive distribution agreement for the Republic of Poland for its RecoveryRx® product line with Med&Care, Gdynia, … Continue Reading

BioElectronics Expands Italian Distribution

Success In Post-Surgical Market Drives Expansion Into Musculoskeletal And Menstrual Pain Markets FREDERICK, MD, USA, August 6, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it has expanded its distribution in Italy with its current distributor, Biomax by adding its musculoskeletal and menstrual pain products. Biomax, … Continue Reading

BioElectronics Engages Dr. Christine Dumas as Spokesperson and Patient Advocate

Health Care Advocate and Reporter Will Develop Public and Medical Education and Awareness Program FREDERICK, MD.  July 17, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Dr. Christine Dumas as public affairs spokesperson and patient advocate. “We’ve engaged the well-known health care advocate, Dr. Christine Dumas, to develop programs to increase awareness of BioElectronics drug-free treatments for pain,” … Continue Reading

BioElectronics Announces Leading Medical Centers Launch Clinical Trials of ActiPatch® Therapy for Treating Pain and Reducing Drug Use

Trials of ActiPatch® Use For Osteoarthritis in Knees, Pain Control in Hernia Surgery and Lower Back Pain Relief Are Underway FREDERICK, MD.  June 24, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that three clinical trials at leading medical centers around the world have ethics approval and … Continue Reading

BioElectronics Unveils Fourth Generation Family of Drug-Free Pain Relievers

New, Lighter and Water Resistant Products Optimized for Retail Marketplace FREDERICK, MD.  June 19, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced its fourth generation of drug-free, anti-inflammatory medical devices.  The company said the new products are lighter and more shock and water resistant. “We designed this … Continue Reading

BioElectronics Continues FDA Clearance Campaign to Bring Chronic Pain Sufferers Safe, Effective, Inexpensive, Drug-Free Pain Therapy

FREDERICK, Md., June 10, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, which has sold 500,000 devices, without prescriptions, in 57 countries reported that they have received three letters from the Office of Science Integrity.  These letters are virtually identical in denying the firm’s request for the FDA Commissioner … Continue Reading

BioElectronics Receives Working Capital Infusion

Ex-Im Bank Provides Export Financing Support FREDERICK, Md., May 29, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, is pleased to announce it has been issued a $500,000 Line of Credit from Ex-Im Bank to create jobs and assist with export working capital. The funding will enable BioElectronics to … Continue Reading

BioElectronics and Pulsed Shortwave Therapy Make Progress

Public Advisory Panel Accepts FDA’s Class II Re-Classification Suggestion FREDERICK, Md., May 23, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy: The FDA’s Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was held on May 21, … Continue Reading

BioElectronics Presents FDA Reclassification Panel

Confirmation of Physiological Mechanism for Pain Relief FREDERICK, MD — 5/21/2013 — BioElectronics Corp. (OTC Pink: BIEL), the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presenting today to the FDA’s Medical Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments for reclassifying the company’s products for over the … Continue Reading